Terms: = Pancreatic cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
2501 results:
1. [cancer survival analysis in Tianjin, 2010 to 2016].
Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
[No Abstract] [Full Text] [Related]
2. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.
Zeng D; Yu C; Chen S; Zou L; Chen J; Xu L
World J Surg Oncol; 2024 Apr; 22(1):93. PubMed ID: 38605359
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of Serum CA 19-9 as a Diagnostic Marker for pancreatic Malignancy.
Ahmed SMF; Ullah AKM; Mohammed S; Chowdhury ASM; Haque MM; Rana AMM
Mymensingh Med J; 2024 Apr; 33(2):533-539. PubMed ID: 38557537
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of URO17® to improve non-invasive detection of bladder cancer.
Porten SP; Wang EY; Vohra P; Carroll PR; Jahanfard S; Kim NW
Urol Oncol; 2024 Jun; 42(6):176.e21-176.e28. PubMed ID: 38553264
[TBL] [Abstract] [Full Text] [Related]
5. Neutrophil Gelatinase-Associated Lipocalin for the Differentiation of Mucinous pancreatic Cystic Lesions.
Olar MP; Iacobescu M; Bolboacă SD; Pojoga C; Moșteanu O; Seicean R; Rusu I; Banc O; Iuga CA; Seicean A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542201
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.
Huan L; Yu F; Cao D; Zhou H; Qin M; Cao Y
PLoS One; 2024; 19(3):e0295983. PubMed ID: 38451955
[TBL] [Abstract] [Full Text] [Related]
7. cancer Risks Associated With
Fortuno C; Feng BJ; Carroll C; Innella G; Kohlmann W; Lázaro C; Brunet J; Feliubadaló L; Iglesias S; Menéndez M; Teulé A; Ballinger ML; Thomas DM; Campbell A; Field M; Harris M; Kirk J; Pachter N; Poplawski N; Susman R; Tucker K; Wallis M; Williams R; Cops E; Goldgar D; ; James PA; Spurdle AB
JCO Precis Oncol; 2024 Feb; 8():e2300453. PubMed ID: 38412388
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan.
Yamashita K; Oka S; Yamada T; Mitsui K; Yamamoto H; Takahashi K; Shiomi A; Hotta K; Takeuchi Y; Kuwai T; Ishida F; Kudo SE; Saito S; Ueno M; Sunami E; Yamano T; Itabashi M; Ohtsuka K; Kinugasa Y; Matsumoto T; Sugai T; Uraoka T; Kurahara K; Yamaguchi S; Kato T; Okajima M; Kashida H; Akagi Y; Ikematsu H; Ito M; Esaki M; Kawai M; Yao T; Hamada M; Horimatsu T; Koda K; Fukai Y; Komori K; Saitoh Y; Kanemitsu Y; Takamaru H; Yamada K; Nozawa H; Takayama T; Togashi K; Shinto E; Torisu T; Toyoshima A; Ohmiya N; Kato T; Otsuji E; Nagata S; Hashiguchi Y; Sugihara K; Ajioka Y; Tanaka S
J Gastroenterol; 2024 May; 59(5):376-388. PubMed ID: 38411920
[TBL] [Abstract] [Full Text] [Related]
9. Synthesis and Characterization of Short α and β-Mixed Peptides with Excellent Anti-Lipase Activities.
Ahmed N; Asif S; Arfan M; Mahmood Q; Islam A; Gatasheh MK; Zia M
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398517
[TBL] [Abstract] [Full Text] [Related]
10. Leucine rich repeat LGI family member 3: Integrative analyses support its prognostic association with pancreatic adenocarcinoma.
Yun HY
Medicine (Baltimore); 2024 Feb; 103(8):e37183. PubMed ID: 38394487
[TBL] [Abstract] [Full Text] [Related]
11. Utilization of texture features of volumetric ADC maps in differentiating between serous cystadenoma and intraductal papillary neoplasms.
Ansari G; Mirza-Aghazadeh-Attari M; Afyouni S; Mohseni A; Shahbazian H; Kamel IR
Abdom Radiol (NY); 2024 Apr; 49(4):1175-1184. PubMed ID: 38378839
[TBL] [Abstract] [Full Text] [Related]
12. Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease.
Zamani M; Alizadeh-Tabari S; Murad MH; Ananthakrishnan AN; Malekzadeh R; Talley NJ
Aliment Pharmacol Ther; 2024 Apr; 59(8):918-927. PubMed ID: 38372406
[TBL] [Abstract] [Full Text] [Related]
13. Diagnosis and treatment of patients with suspected mucinous cystic neoplasms of the liver: a retrospective cohort study.
Furumaya A; Schulz HH; Verheij J; Takkenberg RB; Besselink MG; Kazemier G; Erdmann JI; van Delden OM
Langenbecks Arch Surg; 2024 Feb; 409(1):66. PubMed ID: 38368313
[TBL] [Abstract] [Full Text] [Related]
14. Plasma tryptophan pathway metabolites quantified by liquid chromatography-tandem mass spectrometry as biomarkers in neuroendocrine tumor patients.
Johansen SU; Hansen T; Nordborg A; Meyer R; Goll R; Florholmen J; Jensen E
J Neuroendocrinol; 2024 Mar; 36(3):e13372. PubMed ID: 38361341
[TBL] [Abstract] [Full Text] [Related]
15. Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases.
Draškovič T; Hauptman N
Sci Rep; 2024 Feb; 14(1):3095. PubMed ID: 38326602
[TBL] [Abstract] [Full Text] [Related]
16. Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Wu JY; Wu JY; Fu YK; Ou XY; Li SQ; Zhang ZB; Zhou JY; Li B; Wang SJ; Chen YF; Yan ML
Ann Surg Oncol; 2024 May; 31(5):3073-3083. PubMed ID: 38316732
[TBL] [Abstract] [Full Text] [Related]
17. Effect of Pringle maneuver on prognosis of patients with colorectal cancer liver metastases after liver resection: a meta-analysis.
An T; Wang Y; Liu L; Wang Y; Deng L; Wu M
Langenbecks Arch Surg; 2024 Feb; 409(1):53. PubMed ID: 38316643
[TBL] [Abstract] [Full Text] [Related]
18. [Short-term outcomes of the TRIANGLE operation after neoadjuvant chemotherapy in locally advanced pancreatic cancer].
Xu D; Tu M; Zhang K; Wu PF; Lyu N; Wang QQ; Yin J; Wu Y; Lu ZP; Chen JM; Xi CH; Wei JS; Guo F; Miao Y; Jiang KR
Zhonghua Wai Ke Za Zhi; 2024 Feb; 62(2):147-154. PubMed ID: 38310383
[No Abstract] [Full Text] [Related]
19. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract] [Full Text] [Related]
20. Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer.
Agnihotri N; Ambavane A; Fan L; Li W; Yoo H; Joo S; Muston D
Pancreatology; 2024 Mar; 24(2):271-278. PubMed ID: 38286712
[TBL] [Abstract] [Full Text] [Related]
[Next]
